Trials / Completed
CompletedNCT00767832
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Detailed description
The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). TEG is a point-of-care device which measures the viscoelastic properties of clot formation. This device can provide rapid and detailed information about coagulation changes in the perioperative period. We will compare coagulation data collected from the study to assess potential coagulation changes associated with Hemoglobin changes before and after surgery, and related to estimated blood loss.
Conditions
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-10-07
- Last updated
- 2009-11-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00767832. Inclusion in this directory is not an endorsement.